Tuesday, 19 August 2025

Concurrent Immune Thrombocytopenia and Crohn’s Disease: A Review of Reported Cases |Chapter 4 | An Overview of Disease and Health Research Vol. 5

 

Background and Aim: The coexistence of immune thrombocytopenia (ITP) and Crohn’s disease (CD) is not common. This review investigated studies involving cases of concurrent ITP and CD.

 

Methods: A literature search and review of studies on patients with comorbid ITP and CD, excluding those with drug- or vaccination-induced ITP, was conducted.

 

Results: Of the 32 cases included in this review, 17 (53.1%) were men, and 15 (46.9%) were women. Ten (31.3%) patients were initially diagnosed with ITP, and 12 (37.5%) with CD. Meanwhile, 10 (31.3%) patients were simultaneously diagnosed with ITP and CD. The development of ITP might be associated with CD aggravation in some cases. The standard therapeutic approaches for comorbid ITP and CD were glucocorticoids, intravenous immunoglobulin, biologics, and splenectomy. However, ITP remission might be achieved with bowel resection for CD. No fatalities were reported.

 

Conclusion: In the reported cases of comorbid ITP and CD, no clear trends were observed regarding sex and preceding disease. Nevertheless, the prognosis in these cases can be favourable.

 

Author(s) Details

 

Toru Shizuma
Department of Physiology, Tokai University School of Medicine, 143, Shimokasuya, Isehara, Kanagawa 259-1193, Japan.

 

Please see the book here:- https://doi.org/10.9734/bpi/aodhr/v5/6056

 

No comments:

Post a Comment